Pierre Boyer

Les Laboratoires Servier SAS manufactures medicines for the treatment of diabetes, venous disease, and cancer. It also offers pharmaceutical products for cardiovascular illnesses such as hypertension, heart failure, and stroke. The company was founded by Jacques Servier in 1954 and is headquartered in Suresnes, France.

Part of Servier SAS, Servier Research & Development Ltd. is a British company that provides research and development services for biotechnology. The company is based in Slough, UK.

Part of Servier SAS, SARL Technologie Servier is a company based in Orleans, France. The French company is a subsidiary of Servier and employs 4800 people in R & D, industry, and other activities of the group. The company's website provides information about the French subsidiary of Servier.

Servier Laboratories Ltd. develops and manufactures pharmaceuticals. Its product portfolio includes Lonsurf, Oncaspar, Pixuvri, Valdoxan, and Natrilix. The company was founded in 1964 and is headquartered in Stoke Poges, the United Kingdom.

Part of Servier SAS, Servier Pharmaceuticals LLC is a privately held pharmaceutical company focused on oncology. The company, based in Boston, MA, was founded in 1954. Servier Pharmaceuticals is committed to innovation and improving the lives of patients, their families, and caregivers. The company invests in research and development to address the unmet needs of patients, particularly in the areas of oncology, cardiovascular diseases, cancers, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. The company offers financial assistance to support patients, advocacy groups, and healthcare professionals. The company strives for transparency in clinical trials and research and development. Servier Pharmaceuticals aims to create a brighter future for all by providing life-saving treatments to a greater number of patients. The company actively seeks alliances, acquisitions, licensing deals, and partnerships to accelerate access to therapies. David K. Lee has been the CEO of the company since 2018.

Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954.